Medical Supplies News
Stay updated on medical supplies with press releases highlighting industry news, trends, and innovations shaping healthcare products. Learn about key developments in medical supplies and explore opportunities in healthcare logistics and supply chain management.
Apr 16, 2026 at 4:15 PM
Bio-Rad to Report First-Quarter 2026 Financial Results on Thursday, April 30, 2026
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the first quarter of 2026 on Thursday, April 30, 2026, following the close of the market. Management will discuss these results in a conference call scheduled for 2:00 PM Pacific Time (5:00 PM Eastern Time) that day. To participate, dial (800) 715-9871 within the U.S. or (646) 307-1963 outside the U...
Apr 16, 2026 at 4:05 PM
FIGS Announces Date of First Quarter 2026 Earnings Release, Conference Call and Webcast
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its first quarter 2026 financial results on Thursday, May 7, 2026, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a first quarter 2026 fin...
Apr 16, 2026 at 10:03 AM
Clinical Trial Shows that Treatment with Kerecis Intact Fish-Skin Grafts Shortens Hospital Stays for Severely Burned Patients
ORLANDO, Fla.--(BUSINESS WIRE)--Study shows Kerecis fish-skin grafts reduce hospital stays for burn patients by 9.3 days compared to synthetic grafts, with lower complication rates....
Apr 16, 2026 at 8:45 AM
CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA® (narsoplimab-wuug)
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) has assigned a permanent Healthcare Common Procedure Coding System (HCPCS) J-code for YARTEMLEA®. The J-code for YARTEMLEA (J1289) simplifies and streamlines billing and reimbursement for patients covered by U.S. government programs (e.g., Medicare) and commercial payers. The J-code will become effective July 1, 2026. “For patients with TA-TMA, access to e...
Apr 16, 2026 at 8:00 AM
Takara Bio USA, Inc. Launches Certified Service Provider Program to Advance Research Using NGS and Single-Cell Technologies
SAN JOSE, Calif.--(BUSINESS WIRE)--Takara Bio USA, Inc. today announced the launch of its CSP Program and announced the certification of Admera Health on the Shasta® system....
Apr 16, 2026 at 8:00 AM
KORU Medical Systems to Report First Quarter 2026 Financial Results on May 6, 2026
MAHWAH, NJ--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report first quarter 2026 financial results on Wednesday, May 6, 2026. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the...
Apr 15, 2026 at 5:30 PM
Covalon Technologies Reports Significant Milestones Spanning Vascular Access, Infection Prevention, and Wound Care
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (TSX: COV; OTCQX: CVALF), an advanced medical technologies company, today announced a series of important milestones reflecting the Company's growing market development and commercial momentum, and deepening engagement across the vascular access, infection prevention, and wound care sectors. Strong Engagement at Infusion Nurses Society Annual Meeting Covalon had a strong presence at the Infusion Nurses Society (INS) Annual Meeting...
Apr 15, 2026 at 9:51 AM
Pangea Pharmaceuticals Announces U.S. Launch of Sdamlo™, the First and Only FDA-Approved, Amlodipine Powder for Oral Solution
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Sdamlo, by Pangea Pharmaceuticals, is an FDA-approved amlodipine, unit-dose, alcohol-free solution for pediatric, geriatric, and tube-fed patients....
Apr 15, 2026 at 8:04 AM
Home Instead and Hilarity for Charity Expand Partnership to Support Families Facing Alzheimer’s
OMAHA, Neb.--(BUSINESS WIRE)--Home Instead, an Honor company, and the world’s leading provider of in-home care for older adults, and Hilarity for Charity (HFC), the nonprofit founded by Seth Rogen and Lauren Miller Rogen, today announced an expanded national partnership to support families navigating Alzheimer’s disease. Building on a longstanding relationship, the collaboration names Home Instead as the preferred home care provider for HFC’s Caregiver Grant Program. The HFC Alzheimer’s and Dem...
Apr 15, 2026 at 4:05 AM
Atelerix Forms Strategic Partnership With JH Health Ltd to Expand Non-Cryogenic Cell Preservation Capabilities in the Middle East
NEWCASTLE, England--(BUSINESS WIRE)--Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has established a strategic partnership with JH Health Ltd, a Saudi Arabian company focused on medical and health-related technology. The partnership grants JH Health exclusive rights to use and distribute Atelerix’s hydrogel-based cell and tissue preservation solutions in the Middle East, significan...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.